DBCO-PEG3-propionic EVCit-PAB
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


DBCO-PEG3-propionic EVCit-PAB
Description :
DBCO-PEG3-propionic EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) [1]. DBCO-PEG3-propionic EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.UNSPSC :
12352203Hazard Statement :
H302-H315-H319-H335Target :
ADC LinkerType :
ADC RelatedRelated Pathways :
Antibody-drug Conjugate/ADC RelatedApplications :
Cancer-programmed cell deathField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/dbco-peg4-propionic-evcit-pab.htmlSolubility :
10 mM in DMSOSmiles :
O=C(CCC(NCCOCCOCCOCCC(N[C@@H](CCC(OC(C)(C)C)=O)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=O)C(NC1=CC=C(CO)C=C1)=O)=O)=O)=O)=O)N2C3=CC=CC=C3C#CC4=CC=CC=C4C2Molecular Formula :
C55H74N8O13Molecular Weight :
1055.22Precautions :
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501References & Citations :
[1]Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16 (5) :315-337.Shipping Conditions :
Room temperatureScientific Category :
ADC RelatedClinical Information :
No Development ReportedIsoform :
Cleavable Linker; Protease Cleavable Linker

